<DOC>
	<DOCNO>NCT00006469</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining treatment surgery may kill tumor cell patient non-small cell lung cancer . PURPOSE : Phase II trial study effectiveness combine chemotherapy radiation therapy surgery treat patient stage IIB non-small cell lung cancer stage IIIA non-small cell lung cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Radiation Therapy Followed By Surgery Treating Patients With Stage IIB Stage IIIA Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate , duration response , survival patient bulky stage IIB stage IIIA non-small cell lung cancer treat paclitaxel , carboplatin , radiotherapy follow surgical resection . - Assess toxicity regimen patient population . OUTLINE : This multicenter study . Patients receive paclitaxel IV 1 hour carboplatin IV 30 minute weekly 5 week . Patients also undergo concurrent radiotherapy daily 5 day week 5 week absence unacceptable toxicity . At approximately 4 week completion chemoradiotherapy , patient stable regressive disease undergo surgical resection . If disease unresectable , patient receive additional 2 week radiotherapy . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 29-30 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm bulky stage IIB stage IIIA nonsmall cell lung cancer Ipsilateral mediastinal node involvement mediastinoscopy No contralateral lymph node involvement No malignant pleural effusion No distant metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Granulocyte count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 10 g/dL Hepatic : ALT/AST le 2 time upper limit normal Bilirubin great 1.5 mg/dL Renal : Creatinine great 2.0 mg/dL Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No prior malignancy within past 5 year except adequately treat carcinoma situ cervix nonmelanoma skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
</DOC>